American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand 
Amazon Explores AI Content Marketplace With Media Publishers 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
LOS ANGELES, Calif., Dec. 19, 2017 -- Strategic Directions International (SDi), a division of BioInformatics LLC, announced today the 2018 Global Assessment Report: The Laboratory Analytical & Life Science Instrumentation Industry will be released in conjunction with PITTCON, which will take place from February 26 - March 1, 2018. The report is widely considered to be the gold standard of market intelligence for the $50+ billion laboratory market for analytical and life science instruments. The report can be pre-purchased at a significant discount as part of the Company’s 2018 subscription plan.
The report will update projections made in 2017 where market conditions have contributed to growth or contraction. As in the past, detailed information on 82 different product categories is presented in 10 sections that include chromatography, life science instrumentation, mass spectrometry, molecular spectroscopy, atomic spectroscopy, surface science, materials characterization, lab automation, general analytical techniques, and lab equipment.
For this first time, users of the report will have an option to receive an electronic data stream updating the market projections on a quarterly basis.
The announcement was made at the unveiling of the combined SDi/BioInformatics market intelligence portfolio of reports for 2018 that includes 15 titles on both emerging and established markets and the Global Assessment report quarterly data stream. Heavily discounted prices are available for companies that subscribe before year’s end. Corporate subscribers will also receive unlimited access to all market research reports published in the last five years by both SDi and BioInformatics.
ABOUT IBO and BIOINFORMATICS LLC
Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics LLC in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.
www.gene2drug.com
For more information contact: Mike Tice Vice President of Markets & Strategy Strategic Directions International A division of BioInformatics LLC 6242 Westchester Parkway, Suite 100 Los Angeles, CA 90045-4820 United States Phone: 310.641.4982 [email protected] www.gene2drug.com
